OWCP, like any OTC, has limited access to capital. These companies often rely on convertible notes to fund operations, including research and development. The notes (debt) will likely be converted to equity at a discount to the market price of the stock. Now here is the rub, the maximum conversion price is .20 without a floor. So, using a worse case type example, if the pps dropped to .10 the $5,000,000.00 could be converted to 50,000,000 shares. The holder of the note could then sell all or some of the stock purchased at a discount into the market. Such an activity could cause a problem similar to JF selling his stock.
But for the faithful: Our management team entered into what amounts to a smart bridge loan. They needed to keep their heads above water in order to complete the trials and stay on track. When the news comes that we have all been waiting the Company stock and operations should move upward and forward respectively. I think it is likely this investment will be enough to spur a level of growth that might easily absorb the impact of any increase in the number of shares issued and outstanding.
We are at the beginning of trail that will become a path to a road of riches. ..................at least give this lady another nine months.
(4)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links